Brief: Torrent Pharma Says To Launch Generic Oral Semaglutide In India
March 21 (Reuters) - Torrent Pharmaceuticals Ltd TORP.NS: TORRENT PHARMA - PHARMA FIRST TO LAUNCH GENERIC ORAL SEMAGLUTIDE IN INDIA TORRENT PHARMA - PHARMA LAUNCHES SEMBOLIC AND SEMALIX SEMAGLUTIDE BRANDS IN INDIA TORRENT PHARMA: LAUNCHED WITH A STARTING PRICE RS. 3,999 PER MONTH Source text: ID:nBSEc4wZtW Further company coverage: TORP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says